KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Royalty Pharma (RPRX) Return on Equity (2020 - 2025)

Royalty Pharma (RPRX) has disclosed Return on Equity for 6 consecutive years, with 0.14% as the latest value for Q4 2025.

  • Quarterly Return on Equity rose 1.0% to 0.14% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.14% through Dec 2025, up 1.0% year-over-year, with the annual reading at 0.13% for FY2025, 0.0% changed from the prior year.
  • Return on Equity hit 0.14% in Q4 2025 for Royalty Pharma, up from 0.14% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.19% in Q2 2021 to a low of 0.02% in Q4 2022.
  • Historically, Return on Equity has averaged 0.12% across 5 years, with a median of 0.12% in 2021.
  • Biggest five-year swings in Return on Equity: decreased -15bps in 2021 and later rose 15bps in 2023.
  • Year by year, Return on Equity stood at 0.12% in 2021, then crashed by -81bps to 0.02% in 2022, then surged by 649bps to 0.17% in 2023, then fell by -25bps to 0.13% in 2024, then increased by 6bps to 0.14% in 2025.
  • Business Quant data shows Return on Equity for RPRX at 0.14% in Q4 2025, 0.14% in Q3 2025, and 0.17% in Q2 2025.